KUALA LUMPUR: A new affordable Hepatitis C treatment – with Malaysian involvement in clinical trials – has shown a 97% cure rate and is able to treat the most severe form of the disease.
The treatment, which uses the drug ravidasvir in combination with a generic version of sofosbuvir, has been shown to be safe and effective, with extremely high cure rates for patients including hard-to-treat cases, according to interim trial results.
